To be screened or not to be screened? Modeling the consequences of PSA screening for the individual

BACKGROUND: Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but may advance diagnosis and treatment in time and lead to overdetection and overtreatment. We estimated benefits and adverse effects of PSA screening for individuals who are deciding whether or not to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wever, E M, Hugosson, J, Heijnsdijk, E A M, Bangma, C H, Draisma, G, de Koning, H J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425982/
https://www.ncbi.nlm.nih.gov/pubmed/22805324
http://dx.doi.org/10.1038/bjc.2012.317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425982/
https://www.ncbi.nlm.nih.gov/pubmed/22805324
http://dx.doi.org/10.1038/bjc.2012.317

Ejemplares similares